Diabetic kidney disease: a report from an ADA Consensus Conference - PubMed (original) (raw)
doi: 10.1053/j.ajkd.2014.08.001.
George L Bakris 2, Rudolf W Bilous 3, Jane L Chiang 4, Ian H de Boer 5, Jordi Goldstein-Fuchs 6, Irl B Hirsch 7, Kamyar Kalantar-Zadeh 8, Andrew S Narva 9, Sankar D Navaneethan 10, Joshua J Neumiller 11, Uptal D Patel 12, Robert E Ratner 13, Adam T Whaley-Connell 14, Mark E Molitch 15
Affiliations
- PMID: 25257325
- DOI: 10.1053/j.ajkd.2014.08.001
Free article
Diabetic kidney disease: a report from an ADA Consensus Conference
Katherine R Tuttle et al. Am J Kidney Dis. 2014 Oct.
Free article
Abstract
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to the increase in type 2 diabetes. This overall increase in the number of people with diabetes has had a major impact on development of diabetic kidney disease (DKD), one of the most frequent complications of both types of diabetes. DKD is the leading cause of end-stage renal disease (ESRD), accounting for approximately 50% of cases in the developed world. Although incidence rates for ESRD attributable to DKD have recently stabilized, these rates continue to rise in high-risk groups such as middle-aged African Americans, Native Americans, and Hispanics. The costs of care for people with DKD are extraordinarily high. In the Medicare population alone, DKD-related expenditures among this mostly older group were nearly $25 billion in 2011. Due to the high human and societal costs, the Consensus Conference on Chronic Kidney Disease and Diabetes was convened by the American Diabetes Association in collaboration with the American Society of Nephrology and the National Kidney Foundation to appraise issues regarding patient management, highlighting current practices and new directions. Major topic areas in DKD included (1) identification and monitoring, (2) cardiovascular disease and management of dyslipidemia, (3) hypertension and use of renin-angiotensin-aldosterone system blockade and mineralocorticoid receptor blockade, (4) glycemia measurement, hypoglycemia, and drug therapies, (5) nutrition and general care in advanced-stage chronic kidney disease, (6) children and adolescents, and (7) multidisciplinary approaches and medical home models for health care delivery. This current state summary and research recommendations are designed to guide advances in care and the generation of new knowledge that will meaningfully improve life for people with DKD.
Keywords: cardiovascular disease; chronic kidney disease (CKD); diabetes mellitus; diabetic kidney disease (DKD); end-stage renal disease (ESRD); glycemia; hypertension; medical home; nutrition.
Copyright © 2014 American Diabetes Association and the National Kidney Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
- Diabetic kidney disease: a report from an ADA Consensus Conference.
Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Tuttle KR, et al. Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296. Diabetes Care. 2014. PMID: 25249672 Free PMC article. - Management of the diabetic patient with advanced chronic kidney disease.
Alicic RZ, Tuttle KR. Alicic RZ, et al. Semin Dial. 2010 Mar-Apr;23(2):140-7. doi: 10.1111/j.1525-139X.2010.00700.x. Epub 2010 Mar 30. Semin Dial. 2010. PMID: 20374553 Review. - Epidemiology of diabetic kidney disease.
Reutens AT. Reutens AT. Med Clin North Am. 2013 Jan;97(1):1-18. doi: 10.1016/j.mcna.2012.10.001. Med Clin North Am. 2013. PMID: 23290726 Review. - Clinical challenges in diagnosis and management of diabetic kidney disease.
Stanton RC. Stanton RC. Am J Kidney Dis. 2014 Feb;63(2 Suppl 2):S3-21. doi: 10.1053/j.ajkd.2013.10.050. Am J Kidney Dis. 2014. PMID: 24461728 Review. - To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
St Peter WL, Odum LE, Whaley-Connell AT. St Peter WL, et al. Pharmacotherapy. 2013 May;33(5):496-514. doi: 10.1002/phar.1232. Epub 2013 Apr 9. Pharmacotherapy. 2013. PMID: 23576066 Review.
Cited by
- Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease.
Song L, Wang K, Yin J, Yang Y, Li B, Zhang D, Wang H, Wang W, Zhan W, Guo C, Gu Z, Wang L, Zeng Z, Bei W, Rong X, Guo J. Song L, et al. Chin Med. 2022 Aug 30;17(1):102. doi: 10.1186/s13020-022-00648-x. Chin Med. 2022. PMID: 36042482 Free PMC article. - Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1.
Yang Y, Wang Y, He Z, Liu Y, Chen C, Wang Y, Wang DW, Wang H. Yang Y, et al. Front Pharmacol. 2020 Jul 29;11:1136. doi: 10.3389/fphar.2020.01136. eCollection 2020. Front Pharmacol. 2020. PMID: 32848753 Free PMC article. - GC × GC-TOFMS metabolomics analysis identifies elevated levels of plasma sugars and sugar alcohols in diabetic mellitus patients with kidney failure.
Duangkumpha K, Jariyasopit N, Wanichthanarak K, Dhakal E, Wisanpitayakorn P, Thotsiri S, Sirivatanauksorn Y, Kitiyakara C, Sathirapongsasuti N, Khoomrung S. Duangkumpha K, et al. J Biol Chem. 2022 Oct;298(10):102445. doi: 10.1016/j.jbc.2022.102445. Epub 2022 Aug 31. J Biol Chem. 2022. PMID: 36055403 Free PMC article. - MAPK1 Mediates MAM Disruption and Mitochondrial Dysfunction in Diabetic Kidney Disease via the PACS-2-Dependent Mechanism.
Liu S, Han S, Wang C, Chen H, Xu Q, Feng S, Wang Y, Yao J, Zhou Q, Tang X, Lin L, Hu L, Davidson AJ, Yang B, Ye C, Yang F, Mao J, Tong C, Chen J, Jiang H. Liu S, et al. Int J Biol Sci. 2024 Jan 1;20(2):569-584. doi: 10.7150/ijbs.89291. eCollection 2024. Int J Biol Sci. 2024. PMID: 38169625 Free PMC article. - An Indole-2-Carboxamide Derivative, LG4, Alleviates Diabetic Kidney Disease Through Inhibiting MAPK-Mediated Inflammatory Responses.
Qian J, Yin S, Ye L, Wang Z, Shu S, Mou Z, Xu M, Chattipakorn N, Liu Z, Liang G. Qian J, et al. J Inflamm Res. 2021 Apr 27;14:1633-1645. doi: 10.2147/JIR.S308353. eCollection 2021. J Inflamm Res. 2021. PMID: 33948087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials